Signal integration between IFNγ and TLR signalling pathways in macrophages

Immunobiology

Volumn 211, Issue 6-8, 2006, Pages 511-524

  Schroder, Kate ^a,b   Sweet, Matthew J ^a,b   Hume, David A ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Cooperative Research Centre for Chronic Inflammatory Diseases ^*  (Australia)

Author keywords

CpG DNA; Endotoxin tolerance; Interferon; Lipopolysaccharide; Nitric oxide; STAT1; Toll like receptor

Indexed keywords

DNA; GAMMA INTERFERON; HISTONE DEACETYLASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRATION HOST FACTOR; JANUS KINASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; STAT1 PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR;

CPG ISLAND; EFFECTOR CELL; GENE TARGETING; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; PHYSIOLOGY;

ANIMALS; HUMANS; INTERFERON TYPE II; MACROPHAGES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 33747346235     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2006.05.007     Document Type: Review

References (108)

1. Aderem A., and Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 406 (2000) 782-787
2. Adib-Conquy M., and Cavaillon J.M. Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. J. Biol. Chem. 277 (2002) 27927-27934
3. Ahmad-Nejad P., Hacker H., Rutz M., Bauer S., Vabulas R.M., and Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32 (2002) 1958-1968
4. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
5. Aung H.T., Schroder K., Himes S.R., Brion K., van Zuylen W., Trieu A., Suzuki H., Hayashizaki Y., Hume D.A., Sweet M.J., and Ravasi T. LPS regulates pro-inflammatory gene expression in macrophages by altering histone deacetylase expression. FASEB J. (2006) (in press)
6. Bauer S., Kirschning C.J., Hacker H., Redecke V., Hausmann S., Akira S., Wagner H., and Lipford G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98 (2001) 9237-9242
7. Blanchette J., Jaramillo M., and Olivier M. Signalling events involved in interferon-gamma-inducible macrophage nitric oxide generation. Immunology 108 (2003) 513-522
8. Boehm U., Klamp T., Groot M., and Howard J.C. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15 (1997) 749-795
9. Bonnert T.P., Garka K.E., Parnet P., Sonoda G., Testa J.R., and Sims J.E. The cloning and characterization of human MyD88: a member of an IL-1 receptor related family. FEBS Lett. 402 (1997) 81-84
10. Bosisio D., Polentarutti N., Sironi M., Bernasconi S., Miyake K., Webb G.R., Martin M.U., Mantovani A., and Muzio M. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99 (2002) 3427-3431
11. Brint E.K., Xu D., Liu H., Dunne A., McKenzie A.N., O'Neill L.A., and Liew F.Y. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5 (2004) 373-379
12. Bundschuh D.S., Barsig J., Hartung T., Randow F., Docke W.D., Volk H.D., and Wendel A. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. J. Immunol. 158 (1997) 2862-2871
13. Buras J.A., Reenstra W.R., and Fenton M.J. NF beta A, a factor required for maximal interleukin-1 beta gene expression is identical to the ets family member PU.1. Evidence for structural alteration following LPS activation. Mol. Immunol. 32 (1995) 541-554
14. Burns K., Martinon F., Esslinger C., Pahl H., Schneider P., Bodmer J.L., Di Marco F., French L., and Tschopp J. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273 (1998) 12203-12209
15. Caldenhoven E., Coffer P., Yuan J., Van de Stolpe A., Horn F., Kruijer W., and Van der Saag P.T. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response element. J. Biol. Chem. 269 (1994) 21146-21154
16. Car B.D., Eng V.M., Schnyder B., Ozmen L., Huang S., Gallay P., Heumann D., Aguet M., and Ryffel B. Interferon gamma receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179 (1994) 1437-1444
17. Carter R.W., Sweet M.J., Xu D., Klemenz R., Liew F.Y., and Chan W.L. Regulation of ST2L expression on T helper (Th) type 2 cells. Eur. J. Immunol. 31 (2001) 2979-2985
18. Cherayil B.J. How not to get bugged by bugs: mechanisms of cellular tolerance to microorganisms. Curr. Opin. Gastroenterol. 19 (2003) 572-577
19. Costelloe E.O., Stacey K.J., Antalis T.M., and Hume D.A. Regulation of the plasminogen activator inhibitor-2 (PAI-2) gene in murine macrophages. Demonstration of a novel pattern of responsiveness to bacterial endotoxin. J. Leukoc. Biol. 66 (1999) 172-182
20. Cramer L.A., Nelson S.L., and Klemsz M.J. Synergistic induction of the Tap-1 gene by IFN-gamma and lipopolysaccharide in macrophages is regulated by STAT1. J. Immunol. 165 (2000) 3190-3197
21. Crespo A., Filla M.B., and Murphy W.J. Low responsiveness to IFN-gamma, after pretreatment of mouse macrophages with lipopolysaccharides, develops via diverse regulatory pathways. Eur. J. Immunol. 32 (2002) 710-719
22. Dalpke A.H., Eckerle S., Frey M., and Heeg K. Triggering of Toll-like receptors modulates IFN-gamma signaling: involvement of serine 727 STAT1 phosphorylation and suppressors of cytokine signaling. Eur. J. Immunol. 33 (2003) 1776-1787
23. Darmani H., Parton J., Harwood J.L., and Jackson S.K. Interferon-gamma and polyunsaturated fatty acids increase the binding of lipopolysaccharide to macrophages. Int. J. Exp. Pathol. 75 (1994) 363-368
24. de Wit H., Hoogstraten D., Halie R.M., and Vellenga E. Interferon-gamma modulates the lipopolysaccharide-induced expression of AP-1 and NF-kappa B at the mRNA and protein level in human monocytes. Exp. Hematol. 24 (1996) 228-235
25. Ferrero E., Jiao D., Tsuberi B.Z., Tesio L., Rong G.W., Haziot A., and Goyert S.M. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc. Natl. Acad. Sci. USA 90 (1993) 2380-2384
26. Gao J., Morrison D.C., Parmely T.J., Russell S.W., and Murphy W.J. An interferon-gamma-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-gamma and lipopolysaccharide. J. Biol. Chem. 272 (1997) 1226-1230
27. Gao J.J., Filla M.B., Fultz M.J., Vogel S.N., Russell S.W., and Murphy W.J. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene. J. Immunol. 161 (1998) 4803-4810
28. Gao J.J., Zuvanich E.G., Xue Q., Horn D.L., Silverstein R., and Morrison D.C. Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. J. Immunol. 163 (1999) 4095-4099
29. Gessani S., Belardelli F., Pecorelli A., Puddu P., and Baglioni C. Bacterial lipopolysaccharide and gamma interferon induce transcription of beta interferon mRNA and interferon secretion in murine macrophages. J. Virol. 63 (1989) 2785-2789
30. Goerdt S., Politz O., Schledzewski K., Birk R., Gratchev A., Guillot P., Hakiy N., Klemke C.D., Dippel E., Kodelja V., and Orfanos C.E. Alternative versus classical activation of macrophages. Pathobiology 67 (1999) 222-226
31. Harada H., Takahashi E., Itoh S., Harada K., Hori T.A., and Taniguchi T. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol. Cell. Biol. 14 (1994) 1500-1509
32. Held T.K., Weihua X., Yuan L., Kalvakolanu D.V., and Cross A.S. Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect. Immun. 67 (1999) 206-212
33. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
34. Hoffmann J.A., Kafatos F.C., Janeway C.A., and Ezekowitz R.A. Phylogenetic perspectives in innate immunity. Science 284 (1999) 1313-1318
35. Honda K., Ohba Y., Yanai H., Negishi H., Mizutani T., Takaoka A., Taya C., and Taniguchi T. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434 (2005) 1035-1040
36. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., and Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777
37. Jahnke A., and Johnson J.P. Synergistic activation of intercellular adhesion molecule 1 (ICAM-1) by TNF-alpha and IFN-gamma is mediated by p65/p50 and p65/c-Rel and interferon-responsive factor Stat1 alpha (p91) that can be activated by both IFN-gamma and IFN-alpha. FEBS Lett. 354 (1994) 220-226
38. Jurkovich G.J., Mileski W.J., Maier R.V., Winn R.K., and Rice C.L. Interferon gamma increases sensitivity to endotoxin. J. Surg. Res. 51 (1991) 197-203
39. Kakuda D.K., Sweet M.J., Mac Leod C.L., Hume D.A., and Markovich D. CAT2-mediated L-arginine transport and nitric oxide production in activated macrophages. Biochem. J. 340 Pt 2 (1999) 549-553
40. Kamijo R., Le J., Shapiro D., Havell E.A., Huang S., Aguet M., Bosland M., and Vilcek J. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178 (1993) 1435-1440
41. Kanno Y., Kozak C.A., Schindler C., Driggers P.H., Ennist D.L., Gleason S.L., Darnell Jr. J.E., and Ozato K. The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds. Mol. Cell. Biol. 13 (1993) 3951-3963
42. Kawai T., and Akira S. TLR signaling. Cell Death Differ. 13 (2006) 816-825
43. Klampfer L., Huang J., Swaby L.A., and Augenlicht L. Requirement of histone deactylase activity for signaling by STAT1. J. Biol. Chem. 279 (2004) 30358-30368
44. Kovarik P., Stoiber D., Novy M., and Decker T. Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation. EMBO J. 17 (1998) 3660-3668
45. Kramer O.H., Baus D., Knauer S.K., Stein S., Jager E., Stauber R.H., Grez M., Pfitzner E., and Heinzel T. Acetylation of Stat1 modulates NF-kappaB activity. Genes Dev. 20 (2006) 473-485
46. Ledebur H.C., and Parks T.P. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J. Biol. Chem. 270 (1995) 933-943
47. Liew F.Y., Xu D., Brint E.K., and O'Neill L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5 (2005) 446-458
48. Look D.C., Pelletier M.R., and Holtzman M.J. Selective interaction of a subset of interferon-gamma response element-binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells. J. Biol. Chem. 269 (1994) 8952-8958
49. Lorsbach R.B., Murphy W.J., Lowenstein C.J., Snyder S.H., and Russell S.W. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J. Biol. Chem. 268 (1993) 1908-1913
50. Ma X., Chow J.M., Gri G., Carra G., Gerosa F., Wolf S.F., Dzialo R., and Trinchieri G. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med. 183 (1996) 147-157
51. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15 (1997) 323-350
52. Meltzer M.S., Ruco L.P., and Leonard E.J. Macrophage activation for tumor cytotoxicity: mechanisms of macrophage activation by lymphokines. Adv. Exp. Med. Biol. 121B (1979) 381-398
53. Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D., Carver-Moore K., DuBois R.N., Clark R., Aguet M., and Schreiber R.D. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84 (1996) 431-442
54. Mita Y., Dobashi K., Shimizu Y., Nakazawa T., and Mori M. Toll-like receptor 2 and 4 surface expressions on human monocytes are modulated by interferon-gamma and macrophage colony-stimulating factor. Immunol. Lett. 78 (2001) 97-101
55. Mizukoshi E., Kaneko S., Yanagi M., Ohno H., Matsushita E., and Kobayashi K. Upregulation of type I interferon receptor by IFN-gamma. J. Interferon Cytokine Res. 19 (1999) 1019-1023
56. Mochizuki S., Kobayashi M., Suzuki T., Oikawa A., Koseki T., Nishihara T., and Hasegawa K. gamma-Interferon enhances expression of CD14/MyD88 and subsequent responsiveness to lipopolysaccharide from Actinobacillus actinomycetemcomitans in human gingival fibroblasts. J. Periodontal Res. 39 (2004) 333-343
57. Murphy T.L., Cleveland M.G., Kulesza P., Magram J., and Murphy K.M. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol. Cell. Biol. 15 (1995) 5258-5267
58. Nair J.S., DaFonseca C.J., Tjernberg A., Sun W., Darnell Jr. J.E., Chait B.T., and Zhang J.J. Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. Proc. Natl. Acad. Sci. USA 99 (2002) 5971-5976
59. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., Nakanishi K., Kimoto M., Miyake K., Takeda K., and Akira S. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J. Immunol. 164 (2000) 3476-3479
60. Nusinzon I., and Horvath C.M. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc. Natl. Acad. Sci. USA 100 (2003) 14742-14747
61. Ohmori Y., and Hamilton T.A. The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J. Immunol. 154 (1995) 5235-5244
62. Ohmori Y., and Hamilton T.A. Requirement for STAT1 in LPS-induced gene expression in macrophages. J. Leukoc. Biol. 69 (2001) 598-604
63. Ohmori Y., Schreiber R.D., and Hamilton T.A. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J. Biol. Chem. 272 (1997) 14899-14907
64. Pace J.L., Russell S.W., Schreiber R.D., Altman A., and Katz D.H. Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma. Proc. Natl. Acad. Sci. USA 80 (1983) 3782-3786
65. Pace J.L., Russell S.W., Torres B.A., Johnson H.M., and Gray P.W. Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J. Immunol. 130 (1983) 2011-2013
66. Pace J.L., Russell S.W., LeBlanc P.A., and Murasko D.M. Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing. J. Immunol. 134 (1985) 977-981
67. Pine R. Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element. Nucleic Acids Res. 25 (1997) 4346-4354
68. Pongubala J.M., Nagulapalli S., Klemsz M.J., McKercher S.R., Maki R.A., and Atchison M.L. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3′ enhancer activity. Mol. Cell. Biol. 12 (1992) 368-378
69. Pongubala J.M., Van Beveren C., Nagulapalli S., Klemsz M.J., McKercher S.R., Maki R.A., and Atchison M.L. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science 259 (1993) 1622-1625
70. Ramsauer K., Sadzak I., Porras A., Pilz A., Nebreda A.R., Decker T., and Kovarik P. p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation. Proc. Natl. Acad. Sci. USA 99 (2002) 12859-12864
71. Rhee S.H., Jones B.W., Toshchakov V., Vogel S.N., and Fenton M.J. Toll-like receptor 2 and 4 activate STAT1 serine phosphorylation by distinct mechanisms in macrophages. J. Biol. Chem. 278 (2003) 22506-22512
72. Roth P., and Stanley E.R. The biology of CSF-1 and its receptor. Curr. Top. Microbiol. Immunol. 181 (1992) 141-167
73. Roth P., Bartocci A., and Stanley E.R. Lipopolysaccharide induces synthesis of mouse colony-stimulating factor-1 in vivo. J. Immunol. 158 (1997) 3874-3880
74. Ruco L.P., and Meltzer M.S. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions. J. Immunol. 121 (1978) 2035-2042
75. Ruco L.P., and Meltzer M.S. Macrophage activation for tumor cytotoxicity: tumoricidal activity by macrophages from C3H/HeJ mice requires at least two activation stimuli. Cell. Immunol. 41 (1978) 35-51
76. Salazar-Mather T.P., Hamilton T.A., and Biron C.A. A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J. Clin. Invest. 105 (2000) 985-993
77. Schnare M., Holt A.C., Takeda K., Akira S., and Medzhitov R. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88. Curr. Biol. 10 (2000) 1139-1142
78. Schreiber R.D., Pace J.L., Russell S.W., Altman A., and Katz D.H. Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon. J. Immunol. 131 (1983) 826-832
79. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75 (2004) 163-189
80. Sester D.P., Trieu A., Brion K., Schroder K., Ravasi T., Robinson J.A., McDonald R.C., Ripoll V., Wells C.A., Suzuki H., Hayashizaki Y., Stacey K.J., Hume D.A., and Sweet M.J. LPS regulates a set of genes in primary murine macrophages by antagonising CSF-1 action. Immunobiology 210 (2005) 97-107
81. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., and Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189 (1999) 1777-1782
82. Sims S.H., Cha Y., Romine M.F., Gao P.Q., Gottlieb K., and Deisseroth A.B. A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol. Cell. Biol. 13 (1993) 690-702
83. Siren J., Pirhonen J., Julkunen I., and Matikainen S. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J. Immunol. 174 (2005) 1932-1937
84. Stacey K.J., Sweet M.J., and Hume D.A. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157 (1996) 2116-2122
85. Stoiber D., Kovarik P., Cohney S., Johnston J.A., Steinlein P., and Decker T. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-gamma. J. Immunol. 163 (1999) 2640-2647
86. Suzuki M., Hisamatsu T., and Podolsky D.K. Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular toll-like receptor 4-MD-2 complex. Infect. Immun. 71 (2003) 3503-3511
87. Sweet M.J., and Hume D.A. Endotoxin signal transduction in macrophages. J. Leukoc. Biol. 60 (1996) 8-26
88. Sweet M.J., and Hume D.A. CSF-1 as a regulator of macrophage activation and immune responses. Arch. Immunol. Ther. Exp. (Warsz.) 51 (2003) 169-177
89. Sweet M.J., Stacey K.J., Kakuda D.K., Markovich D., and Hume D.A. IFN-gamma primes macrophage responses to bacterial DNA. J. Interferon Cytokine Res. 18 (1998) 263-271
90. Sweet M.J., Campbell C.C., Sester D.P., Xu D., McDonald R.C., Stacey K.J., Hume D.A., and Liew F.Y. Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages. J. Immunol. 168 (2002) 392-399
91. Takauji R., Iho S., Takatsuka H., Yamamoto S., Takahashi T., Kitagawa H., Iwasaki H., Iida R., Yokochi T., and Matsuki T. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors. J. Leukoc. Biol. 72 (2002) 1011-1019
92. Tamai R., Sugawara S., Takeuchi O., Akira S., and Takada H. Synergistic effects of lipopolysaccharide and interferon-gamma in inducing interleukin-8 production in human monocytic THP-1 cells is accompanied by up-regulation of CD14, Toll-like receptor 4, MD-2 and MyD88 expression. J. Endotoxin Res. 9 (2003) 145-153
93. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., Williams B.R., Major J., Hamilton T.A., Fenton M.J., and Vogel S.N. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3 (2002) 392-398
94. Uchijima M., Nagata T., Aoshi T., and Koide Y. IFN-gamma overcomes low responsiveness of myeloid dendritic cells to CpG DNA. Immunol. Cell Biol. 83 (2005) 92-95
95. Uddin S., Lekmine F., Sharma N., Majchrzak B., Mayer I., Young P.R., Bokoch G.M., Fish E.N., and Platanias L.C. The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J. Biol. Chem. 275 (2000) 27634-27640
96. Vadiveloo P.K., Vairo G., Hertzog P., Kola I., and Hamilton J.A. Role of type I interferons during macrophage activation by lipopolysaccharide. Cytokine 12 (2000) 1639-1646
97. Van Uden J.H., Tran C.H., Carson D.A., and Raz E. Type I interferon is required to mount an adaptive response to immunostimulatory DNA. Eur. J. Immunol. 31 (2001) 3281-3290
98. Varinou L., Ramsauer K., Karaghiosoff M., Kolbe T., Pfeffer K., Muller M., and Decker T. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity. Immunity 19 (2003) 793-802
99. Vogel S.N., Fitzgerald K.A., and Fenton M.J. TLRs: Differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Intervent. 3 (2003) 466-477
100. Wang I.M., Contursi C., Masumi A., Ma X., Trinchieri G., and Ozato K. An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J. Immunol. 165 (2000) 271-279
101. Wells C.A., Ravasi T., and Hume D.A. Inflammation suppressor genes: please switch out all the lights. J. Leukoc. Biol. 78 (2005) 9-13
102. Wen Z., Zhong Z., and Darnell Jr. J.E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82 (1995) 241-250
103. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
104. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269 (1994) 4705-4708
105. Yi A.K., Yoon J.G., Yeo S.J., Hong S.C., English B.K., and Krieg A.M. Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response. J. Immunol. 168 (2002) 4711-4720
106. Yoshida A., Koide Y., Uchijima M., and Yoshida T.O. IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774. Biochem. Biophys. Res. Commun. 198 (1994) 857-861
107. Zhao J., Kong H.J., Li H., Huang B., Yang M., Zhu C., Bogunovic M., Zheng F., Mayer L., Ozato K., Unkeless J., and Xiong H. IRF-8/ICSBP is involved in TLR signaling and contributes to the cross talk between TLR and IFN-gamma signaling pathways. J. Biol. Chem. 281 (2006) 10073-10080
108. Ziegler-Heitbrock L. The p50-homodimer mechanism in tolerance to LPS. J. Endotoxin Res. 7 (2001) 219-222